Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3.

Gut - 1 Jun 2011

Patel Harshna, Heathcote E Jenny

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Cyclosporine
Share to Genotype
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Virus Replication

Source

Identifiers

PMID: 20966029
DOI: 10.1136/gut.2010.217323

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3.PMID 20966029Read ↗

Sustained virological response with sofosbuvir and ledipasvir for hepatitis C virus genotype 5.Semantic proximity Read ↗

Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies.Semantic proximity Read ↗

4 ONCE DAILY ALISPORIVIR (DEB025) PLUS PEGIFNALFA2A/RIBAVIRIN RESULTS IN SUPERIOR SUSTAINED VIROLOGIC RESPONSE (SVR24) IN CHRONIC HEPATITIS C GENOTYPE 1 TREATMENT NAIVE PATIENTSSemantic proximity Read ↗

Summaries for patients. Duration and dose of antiviral treatment for chronic hepatitis C.Semantic proximity Read ↗

Treatment of patients with genotype 3 chronic hepatitis C--current and future therapies.Semantic proximity Read ↗

Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options.Semantic proximity Read ↗

MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failureSemantic proximity Read ↗

Successful rescue therapy with only 4 weeks ribavirin monotherapy in end-stage cirrhosis due to genotype 2 chronic hepatitis C.Semantic proximity Read ↗

Hepatitis C genotype 1b and 4 cured after telaprevir-based therapy.Semantic proximity Read ↗

High Svr Rates with ABT-493 + ABT-530 Co-Administered for 8 Weeks in Non-Cirrhotic Patients with HCV Genotype 3 InfectionSemantic proximity Read ↗

Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection.Semantic proximity Read ↗

Individualizing treatment duration in hepatitis C virus genotype 2/3-infected patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.